Improving Everyday Functioning in Adults Aged 70 and Over Using a Multivitamin Supplement
1 other identifier
interventional
228
1 country
1
Brief Summary
Investigation of the chronic effect of 12 week multivitamin supplementation on markers of everyday function in adults aged 70 and over.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2019
CompletedFirst Posted
Study publicly available on registry
October 2, 2019
CompletedStudy Start
First participant enrolled
November 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedJuly 29, 2025
December 1, 2022
1.9 years
August 30, 2019
July 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Well-Being (change from baseline)
An overall outcome measure which is a composite measure made up of four personal well-being questions used in the Measuring National Well-being programme plus one additional question. These five questions are: 1. Overall, how satisfied are you with your life nowadays? 2. Overall, to what extent do you feel the things you do in your life are worthwhile? 3. Overall, how happy did you feel yesterday? 4. Overall, how anxious did you feel yesterday? 5. Overall, how well did you feel yesterday?
Measured at baseline and then following chronic (12 weeks) treatment
Secondary Outcomes (26)
Cardiovascular reactivity- Blood pressure (change from baseline)
Measured at baseline and then following chronic (12 weeks) treatment
Cardiovascular reactivity- Heart rate (change from baseline)
Measured at baseline and then following chronic (12 weeks) treatment
Immune/inflammatory response (change from baseline)
Measured at baseline and then following chronic (12 weeks) treatment
Immune/inflammatory response(change from baseline)
Measured at baseline and then following chronic (12 weeks) treatment
Self-Reported Stress (change from baseline)
Measured at baseline and then following chronic (12 weeks) treatment
- +21 more secondary outcomes
Study Arms (2)
Multivitamin
EXPERIMENTAL1 multivitamin tablet administered by mouth daily for 12 weeks, to be taken with main meal.
Placebo
PLACEBO COMPARATOR1 placebo tablet administered by mouth daily for 12 weeks, to be taken with main meal.
Interventions
Eligibility Criteria
You may qualify if:
- Aged over 70
- Both caregivers and non caregivers will be recrtuied
You may not qualify if:
- Allergy to soya
- Participants must not be currently taking the investigational product (or another equivalent multivitamin); any participants who report multivitamin use must be willing to have a washout for 4 weeks before participating (if not willing to do this they will be excluded)
- If a participant has epilepsy, a thyroid disorder, haemochromatosis or suffers from food allergies they must consult their doctor/pharmacist before taking part
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northumbria Universitylead
- Vitabioticscollaborator
Study Sites (1)
Northumbria University
Newcastle upon Tyne, NE1 8ST, United Kingdom
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2019
First Posted
October 2, 2019
Study Start
November 24, 2019
Primary Completion
September 30, 2021
Study Completion
September 30, 2021
Last Updated
July 29, 2025
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share